Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Palmoplantar Pustulosis Market Forecast Highlighting Growth From $2.25 Billion To $3.02 Billion
The palmoplantar pustulosis market size has grown strongly in recent years. It will grow from $2.09 billion in 2025 to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to limited treatment options for chronic skin conditions, reliance on corticosteroids and topical agents, delayed diagnosis of pustular psoriasis, low patient awareness about disease management, hospital-centric care delivery.
The palmoplantar pustulosis market is projected for significant expansion in the forthcoming years, anticipating a reach of $3.03 billion by 2030, driven by a compound annual growth rate of 7.6%. This projected expansion is largely fueled by the introduction of innovative biologic and systemic treatments, a greater utilization of focused immunomodulators, the increasing prevalence of teledermatology and digital health solutions, a wider acceptance of at-home phototherapy, and enhanced accessibility through online and retail pharmacies. Key developments influencing this growth trajectory include a heightened preference for biologic therapies, expanded application of targeted immunomodulators, broader availability of home-based phototherapy options, the integration of teledermatology for managing long-term skin conditions, and increased access to therapeutic options via online pharmacies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22090&type=smp
Palmoplantar Pustulosis Market Growth Factors Supporting Long-Term Expansion
The palmoplantar pustulosis market is anticipated to experience expansion, largely driven by a rising number of skin condition cases. These skin conditions, characterized by alterations in the skin’s structure, functionality, or visual presentation, are becoming more prevalent due to factors such as environmental shifts, evolving lifestyle choices, and inherent genetic predispositions. External influences like atmospheric contamination, harsh climatic extremes, and contact with hazardous substances can irritate the skin, potentially triggering issues such as eczema or acne. Palmoplantar pustulosis itself is a persistent dermatological ailment that impacts the skin of the hands’ palms and the feet’s soles, manifesting as pustules, redness, and scaling, for which therapeutic interventions exist to enhance skin well-being and ease associated discomfort. Illustrating this trend, data from December 2023, released by the National Institutes of Health (NIH), a leading U.S. medical research institution, indicated that atopic dermatitis affected approximately 2.6% of the global population, impacting an estimated 204 million individuals worldwide, thereby underscoring how the escalating occurrence of skin ailments is a significant catalyst for the growth within the palmoplantar pustulosis market.
Palmoplantar Pustulosis Market Segment Analysis: What Are The Major Market Categories?
The palmoplantar pustulosis market covered in this report is segmented –
1) By Treatment Type: Topical Treatments, Systemic Treatments, Biologics, Phototherapy
2) By Distribution Channel: Online Pharmacies, Retail Pharmacies
3) By Application: Hospitals, Dermatology Clinics, Homecare Settings
Subsegments:
1) By Topical Treatments: Corticosteroids, Vitamin D Analogues, Calcineurin Inhibitors, Keratolytics
2) By Systemic Treatments: Retinoids, Immunosuppressants, Phosphodiesterase-4 (PDE4) Inhibitors, Corticosteroids
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors, Interleukin-12/23 (IL-12/23) Inhibitors
4) By Phototherapy: Narrowband UVB Therapy (NB-UVB), Psoralen plus Ultraviolet A (PUVA) Therapy, Excimer Laser Therapy, Targeted Phototherapy
Palmoplantar Pustulosis Market Industry Trends Shaping Future Revenue Growth
In the palmoplantar pustulosis market, leading entities are concentrating their efforts on pioneering new therapeutic approaches, including monoclonal antibodies aimed at specific inflammatory pathways, with the ultimate goal of enhancing patient results. A monoclonal antibody (mAb) is essentially a uniform antibody, stemming from a solitary B cell lineage, engineered to bind to a particular antigen, serving either diagnostic or therapeutic functions. Demonstrating this trend, Kyowa Kirin Co., Ltd., a pharmaceutical firm headquartered in Japan, secured partial approval for an alteration of its treatment LUMICEF for palmoplantar pustulosis within Japan in August of 2023. LUMICEF functions as a selective treatment by inhibiting IL-17, a mechanism that delivers prompt and enduring alleviation from inflammatory ailments like psoriasis and palmoplantar pustulosis, thereby aiming to diminish inflammation and elevate the standard of living for individuals afflicted by these persistent conditions.
Palmoplantar Pustulosis Market Leading Companies Driving Competitive Growth
Major companies operating in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol‑Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Kamari Pharma Ltd., Johnson & Johnson, AstraZeneca, Eli Lilly and Company, Bayer AG, Merck & Co. Inc., UCB S.A., Boehringer Ingelheim International GmbH, Arcutis Biotherapeutics, Affibody AB, LEO Pharma A/S, Galderma, Incyte Corporation, Takeda Pharmaceutical Company Ltd., Roivant Sciences
Access The Complete Palmoplantar Pustulosis Market Report:
https://www.thebusinessresearchcompany.com/report/palmoplantar-pustulosis-global-market-report
Palmoplantar Pustulosis Market Geographic Analysis: Where Is Demand Growing The Fastest?
North Americawas the largest region in the palmoplantar pustulosis market in 2025. The regions covered in the palmoplantar pustulosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
